1.
Clin Infect Dis
; 72(5): 869-872, 2021 03 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-32472688
RESUMEN
We found low prevalence of SARS-CoV-2 (2.7% [5/188]) among pregnant and postpartum patients with universal testing. Prevalence among symptomatic patients was similar under initial targeted screening (22.2% [4/18]) and universal approaches (19.1% [8/42]). Among 170 asymptomatic patients, 2 were positive or inconclusive, respectively; repeat testing at 24 hours was negative.